...
首页> 外文期刊>Lung cancer: Journal of the International Association for the Study of Lung Cancer >Diagnostic results before and after introduction of autofluorescence bronchoscopy in patients suspected of having lung cancer detected by sputum cytology in lung cancer mass screening.
【24h】

Diagnostic results before and after introduction of autofluorescence bronchoscopy in patients suspected of having lung cancer detected by sputum cytology in lung cancer mass screening.

机译:在肺癌大规模筛查中,通过痰细胞学检查发现怀疑患有肺癌的患者,在进行自体荧光支气管镜检查之前和之后的诊断结果。

获取原文
获取原文并翻译 | 示例

摘要

For the purpose of early detection, we have conducted population-based mass screening for lung cancer by sputum cytology since 1982. Although detection of lung cancer in its early stage is important for a good prognosis, it is often difficult to localize lesions in roentgenographically occult cancer. To clarify the role of autofluorescence bronchoscopy in localizing tumors in patients with roentgenographically occult cancer, we analyzed our diagnostic results. Fifty patients who had been detected by sputum cytology were screened by the light-induced fluorescence endoscope (LIFE)-Lung System from November 1997 to April 1999. We compared the results according to the screening methods: conventional bronchoscopy alone versus LIFE with conventional white-light bronchoscopy (November 1997 to April 1999). Twenty-eight cancerous lesions and 39 borderline lesions were detected by LIFE. Of the 39 borderline lesions, nine were detected only by LIFE. Multicentric lesions including cancer or dysplasia were also detected in 21 of the 50 patients by LIFE. The sensitivity by white-light bronchoscopy alone was 85.3%, whereas that of the LIFE-Lung System with white-light bronchoscopy was 94.1% (P=0.078). There were no cancerous lesions in the area observed as normal by LIFE. We also compared the diagnostic results of two localization methods: brushing of all bronchi (September 1986 to December 1990) and the LIFE-Lung System (November 1997 to April 1999). Although this was a historical comparison, the number of detected borderline lesions increased, which led to a high detection rate in patients with suspected-positive sputum (P=0.0006) by the LIFE-Lung System. In conclusion, the LIFE-Lung System is a safe and non-invasive system for detecting small intraepithelial lesions of the tracheobronchial tree. Autofluorescence bronchoscopy is more efficacious for localizing intraepithelial lesions and places fewer burdens on the patient than brushing of all bronchi.
机译:为了及早发现,我们自1982年以来就开始通过痰细胞学对人群进行肺癌大规模筛查。尽管早期发现肺癌对于良好的预后很重要,但在X线摄片术中通常难以定位病变癌症。为了阐明自发荧光支气管镜检查在X线隐匿性癌症患者中定位肿瘤的作用,我们分析了诊断结果。从1997年11月至1999年4月,对50例经痰细胞学检查发现的患者进行了光诱导荧光内镜(LIFE)-肺系统检查。轻支气管镜检查(1997年11月至1999年4月)。 LIFE检测到28个癌性病变和39个边界性病变。在39个边缘性病变中,只有9个仅通过LIFE检测到。 LIFE还对50例患者中的21例进行了多中心病变的检测,包括癌症或发育不良。单独使用白光支气管镜的敏感性为85.3%,而使用白光支气管镜的LIFE-肺系统的敏感性为94.1%(P = 0.078)。 LIFE观察到的正常区域没有癌变。我们还比较了两种定位方法的诊断结果:刷所有支气管(1986年9月至1990年12月)和LIFE-肺系统(1997年11月至1999年4月)。尽管这是历史比较,但通过LIFE-Lung系统检测出的边缘性病变数量有所增加,这导致痰液阳性怀疑可疑患者(P = 0.0006)的检出率很高。总之,LIFE-肺系统是用于检测气管支气管树上皮内小病变的安全且无创的系统。与所有支气管刷牙相比,自发荧光支气管镜检查对于定位上皮内病变更有效,对患者的负担也更少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号